0.97
price up icon1.31%   0.0125
after-market Handel nachbörslich: .97
loading

Finanzdaten der Salarius Pharmaceuticals Inc-Aktie (SLRX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
82.51%
1.7716
0.9707 2.5322 3.9714 5.4207
Operating Income/Loss
82.51%
-1.7716
-0.9707 -2.5322 -3.9714 -5.4207
Income/Loss From Continuing Operations Before Tax
94.52%
-1.7153
-0.8818 -2.4428 -3.8773 -5.3408
Income/Loss From Continuing Operations After Tax
94.52%
-1.7153
-0.8818 -2.4428 -3.8773 -5.3408
Net Income/Loss
94.52%
-1.7153
-0.8818 -2.4428 -3.8773 -5.3408
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1,747%
4.1946
0.2271 3.754 2.7091 2.392
Diluted Average Shares
1,747%
4.1946
0.2271 3.754 2.7091 2.392
Basic Earnings Per Share
-0.41
- -0.65 -1.43 -2.23
Diluted Earnings Per Share
-0.41
- -0.65 -1.43 -2.23
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$307.24
price up icon 0.61%
$76.55
price up icon 1.97%
$32.77
price up icon 0.28%
$20.79
price up icon 8.34%
$99.47
price up icon 2.06%
biotechnology ONC
$259.19
price up icon 1.81%
Kapitalisierung:     |  Volumen (24h):